Perrigo Co. PLC (PRGO): Price and Financial Metrics


Perrigo Co. PLC (PRGO): $32.12

0.51 (+1.61%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PRGO POWR Grades

  • PRGO scores best on the Growth dimension, with a Growth rank ahead of 97.45% of US stocks.
  • PRGO's strongest trending metric is Growth; it's been moving up over the last 26 weeks.
  • PRGO's current lowest rank is in the Momentum metric (where it is better than 10.86% of US stocks).

PRGO Stock Summary

  • PERRIGO CO PLC's stock had its IPO on December 17, 1991, making it an older stock than 84.37% of US equities in our set.
  • The price/operating cash flow metric for PERRIGO CO PLC is higher than 98.35% of stocks in our set with a positive cash flow.
  • Over the past twelve months, PRGO has reported earnings growth of -96.21%, putting it ahead of just 15.21% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to PERRIGO CO PLC, a group of peers worth examining would be CNMD, FTI, ASUR, MNTX, and TMCI.
  • Visit PRGO's SEC page to see the company's official filings. To visit the company's web site, go to www.perrigo.com.

PRGO Valuation Summary

  • In comparison to the median Healthcare stock, PRGO's EV/EBIT ratio is 10091.36% higher, now standing at 825.5.
  • Over the past 243 months, PRGO's price/sales ratio has gone down 0.1.

Below are key valuation metrics over time for PRGO.

Stock Date P/S P/B P/E EV/EBIT
PRGO 2022-12-05 1 0.9 -39.9 825.5
PRGO 2022-12-02 1 0.9 -40.1 827.4
PRGO 2022-12-01 1 0.9 -40.3 830.2
PRGO 2022-11-30 1 0.9 -40.4 831.4
PRGO 2022-11-29 1 0.9 -40.3 829.5
PRGO 2022-11-28 1 0.9 -40.1 827.8

PRGO Growth Metrics

    Its 3 year revenue growth rate is now at -10.36%.
  • Its year over year net cashflow from operations growth rate is now at -49.38%.
  • The 3 year net income to common stockholders growth rate now stands at -195.96%.
PRGO's revenue has moved down $516,500,000 over the prior 52 months.

The table below shows PRGO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 4,401.3 16 -107.3
2022-06-30 4,343.8 300.6 -116.8
2022-03-31 4,203.2 235.2 -109.4
2021-12-31 4,138.7 156.3 -68.9
2021-09-30 4,323.3 372.1 -253.5
2021-06-30 4,494.3 91.4 -349.2

PRGO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PRGO has a Quality Grade of D, ranking ahead of 9.21% of graded US stocks.
  • PRGO's asset turnover comes in at 0.394 -- ranking 119th of 682 Pharmaceutical Products stocks.
  • TMBR, OCUP, and ORMP are the stocks whose asset turnover ratios are most correlated with PRGO.

The table below shows PRGO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-03 0.394 0.359 -0.038
2021-04-03 0.407 0.359 -0.012
2020-12-31 0.435 0.359 -0.003
2020-09-26 0.439 0.358 0.026
2020-06-27 0.440 0.357 0.064
2020-03-28 0.440 0.361 0.058

PRGO Stock Price Chart Interactive Chart >

Price chart for PRGO

PRGO Price/Volume Stats

Current price $32.12 52-week high $43.90
Prev. close $31.61 52-week low $31.01
Day low $31.66 Volume 1,125,400
Day high $32.74 Avg. volume 1,418,144
50-day MA $36.11 Dividend yield 3.24%
200-day MA $37.90 Market Cap 4.32B

Perrigo Co. PLC (PRGO) Company Bio


Perrigo Company plc is an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. (Source:Wikipedia)


PRGO Latest News Stream


Event/Time News Detail
Loading, please wait...

PRGO Latest Social Stream


Loading social stream, please wait...

View Full PRGO Social Stream

Latest PRGO News From Around the Web

Below are the latest news stories about PERRIGO CO PLC that investors may wish to consider to help them evaluate PRGO as an investment opportunity.

Reckitt Benckiser expects baby formula shortage to continue into spring 2023

Yahoo Finance health care reporter Anjalee Khemlani shares the latest on the ongoing baby formula shortage and how it may extend into spring 2023.

Yahoo | December 1, 2022

‘Long-term investors should turn back toward stocks’: J.P. Morgan says inflation has peaked and suggests 2 stocks to buy

For well over a year now, we’ve been seeing headlines about inflation. The rate of price increases is running at its highest level since the early 1980s, although the October numbers, just released, showed it cooling off to 7.7% over the past 12 months. Covering the markets from investment giant JPMorgan, asset management investment chief David Kelly believes the trends are favorable looking forward. From June to October, the annualized inflation rate dropped from 9.1% to 7.7%, leading him to say, “Inflation has already peaked. I think it is going to gradually fall.

Michael Marcus on TipRanks | November 10, 2022

Perrigo Co PLC (PRGO) Q3 2022 Earnings Call Transcript | AlphaStreet

Perrigo Co PLC (NYSE:PRGO) Q3 2022 Earnings Call dated Nov. 08, 2022.

AlphaStreet | November 10, 2022

Perrigo Co PLC (PRGO) Q3 2022 Earnings Call Transcript

Perrigo Co PLC (NYSE:PRGO) Q3 2022 Earnings Call dated Nov. 08, 2022. Corporate Participants: Bradley Joseph — Vice President, Global Investor Relations and Corporate Communications Murray S. Kessler — President and Chief Executive Officer […] The post Perrigo Co PLC (PRGO) Q3 2022 Earnings Call Transcript first appeared on AlphaStreet .

AlphaStreet | November 10, 2022

Perrigo Shares Fall As Investors React To Lowered FY22 Profit Guidance

Perrigo Company plc''s (NYSE: PRGO) Q3 FY22 sales increased 5.5% Y/Y or 12.3%, excluding the impact of currency translation to $1.10 billion, almost in line with the consensus of $1.10 billion. The growth was led by the acquisition of HRA, strategic pricing actions across Consumer Self-Care segments, and cough/cold-related product sales. Adjusted EPS increased 24.4% to $0.56, up from $0.45 a year ago. "Although … Full story available on Benzinga.com

Benzinga | November 8, 2022

Read More 'PRGO' Stories Here

PRGO Price Returns

1-mo 0.94%
3-mo -17.29%
6-mo -15.70%
1-year -9.78%
3-year -35.88%
5-year -58.65%
YTD -14.99%
2021 -10.95%
2020 -11.97%
2019 35.65%
2018 -55.08%
2017 5.58%

PRGO Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PRGO Dividend History

Continue Researching PRGO

Here are a few links from around the web to help you further your research on PERRIGO Co plc's stock as an investment opportunity:

PERRIGO Co plc (PRGO) Stock Price | Nasdaq
PERRIGO Co plc (PRGO) Stock Quote, History and News - Yahoo Finance
PERRIGO Co plc (PRGO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7328 seconds.